Abiopharma

New Form 6-K - PolyPid Ltd. Filed: 2025-06-09 AccNo: 0001213900-25-052320 Size: 60 KB

New Form 8-K - Catheter Precision, Inc. Filed: 2025-06-09 AccNo: 0001437749-25-019768 Size: 293 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

New Form 8-K - enGene Holdings Inc. Filed: 2025-06-09 AccNo: 0000950170-25-083444 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

PolyPid Announces Positive Topline Results from Phase 3 SHIELD II Trial: D-PLEX₁₀₀ Demonstrated Significant Reduction in Surgical Site Infections and Successfully Met Primary and All Key Secondary Endpoints

New Form 8-K - NewAmsterdam Pharma Co N.V. Filed: 2025-06-09 AccNo: 0001193125-25-137432 Size: 219 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Neurogene Inc. Filed: 2025-06-09 AccNo: 0001404644-25-000049 Size: 6 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - Evolent Health, Inc. Filed: 2025-06-09 AccNo: 0001628908-25-000094 Size: 4 KB

New Form 3 - Evolent Health, Inc. Filed: 2025-06-09 AccNo: 0001628908-25-000092 Size: 790 KB

Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer

New Form 424B3 - PORTAGE BIOTECH INC. Filed: 2025-06-09 AccNo: 0001171843-25-003780 Size: 79 KB

New Form S-4/A - Ikena Oncology, Inc. Filed: 2025-06-09 AccNo: 0001140361-25-021863 Size: 18 MB

New Form 4 - Evolent Health, Inc. Filed: 2025-06-09 AccNo: 0001628908-25-000090 Size: 6 KB

New Form 4 - Evolent Health, Inc. Filed: 2025-06-09 AccNo: 0001628908-25-000088 Size: 4 KB